Myelodysplastic Syndrome

Treatment strategy for MDS will take into consideration the disease risk category, patients’ symptoms and fitness for treatment. 

Patients with MDS may receive one or more of the treatment options below 

• Allogeneic stem cell transplant 
• It is the only treatment that has been shown to cure MDS but it is associated with many severe complications 
• It is usually recommended to patients with high risk disease and are fit for intensive treatment 
  

As the oldest and most established haematology department in Singapore, we have a dedicated group of doctors who specialize not only in the treatment of myelodysplastic syndrome, but also have access to new medication through clinical trials. For high-risk patients and in event of transformation to leukaemia, suitable patients will be transition to the haematopoietic stem cell transplant team.